Psykey, Inc.
Psykey, Inc. (CEOS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ceos · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Psykey, Inc. (CEOS) measures how much investors pay for each dollar of the company's trailing earnings. CEOS's current PE ratio of 0.49x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.01. +54.1% elevated vs 5Y avg 0.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2005 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Psykey, Inc.You CEOS | $0M | 0.49x | — | $0.01 |
 Abattis Bioceuticals Corp. ATTBF | $0M | N/A | — | -$0.01 |
 Health Advance Inc. HADV | $0M | N/A | — | -$0.00 |
 Health Discovery Corporation HDVY | $0M | N/A | — | -$0.00 |
 Instadose Pharma Corp. INSD | $0M | N/A | — | -$0.01 |
 Isodiol International Inc. ISOLF | $0M | N/A | — | -$2.35 |
 Medivolve Inc. MEDVF | $0M | N/A | — | -$0.61 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 0.32x | $0.01 | — | |
2024-12-31 FY2024 | — | $-0.00 | — | |
2023-12-31 FY2023 | — | $-0.00 | — | |
2022-12-31 FY2022 | — | $-0.00 | — | |
2021-12-31 FY2021 | — | $-0.00 | — | |
2020-12-31 FY2020 | — | $0.00 | — | |
2019-12-31 FY2019 | — | $-0.00 | — | |
2018-12-31 FY2018 | — | $-0.00 | — | |
2016-12-31 FY2016 | — | $-0.01 | — | |
2015-12-31 FY2015 | — | $-0.12 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Psykey, Inc. (CEOS) measures how much investors pay for each dollar of the company's trailing earnings. CEOS's current PE ratio of 0.49x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.01.
Frequently asked questions
CEOS pe ratio · 6 questionsCEOS's current PE ratio is 0.49x as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of $0.01. Data sourced from Financial Modeling Prep via CEOS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Psykey, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09